Janney Montgomery Scott’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding NTLA
AIM
NAMA
DTC
Janney Montgomery Scott's NTLA Position: Q4 2023 in Review
Janney Montgomery Scott sold out of Intellia Therapeutics (NTLA) in Q4 2023, closing a stake of 11,862 shares — an estimated $375K sold.
Janney Montgomery Scott first reported a position in NTLA in Q4 2017 and held it in 18 quarters. The position peaked at $1.48M in Q2 2021. 292 funds tracked by Wall St. Rank hold NTLA as of Q4 2023.
- Janney Montgomery Scott reported no remaining Intellia Therapeutics position as of Q4 2023 after selling out during the quarter.
- Janney Montgomery Scott sold 11,862 Intellia Therapeutics shares in Q4 2023, an estimated $375K.
- Janney Montgomery Scott first reported a position in Intellia Therapeutics in Q4 2017 and held it in 18 quarters.
- Janney Montgomery Scott's Intellia Therapeutics position peaked at $1.48M in Q2 2021.
- 292 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2023.
Based on Janney Montgomery Scott's 13F filing for Q4 2023, filed 8 Feb 2024.